Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Grey Wolf HealthTSXV:WOLF 52 PB Ratio is 1.78 as of Jul. 18, 2026, which is 66% above its 10-year median of 1.07. GuruFocus rates TSXV:WOLF with a GF Score™ of 52/100 and a GF Value™ of C$1.10 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 922 Drug Manufacturers companies, Grey Wolf Health ranks better than 53.58% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-18), Grey Wolf Health's share price is C$1.60. Grey Wolf Health's Book Value per Share for the quarter that ended in Mar. 2026 was C$0.90. Hence, Grey Wolf Health's PB Ratio of today is 1.78.
Warning Sign:
Grey Wolf Health Corp stock PB Ratio (=1.95) is close to 5-year high of 1.99.
The historical rank and industry rank for Grey Wolf Health's PB Ratio or its related term are showing as below:
TSXV:WOLF'
s PB Ratio Range Over the Past 10 Years
Min: 0.72 Med: 1.07 Max: 1.99
Current: 1.78
During the past 5 years, Grey Wolf Health's highest PB Ratio was 1.99. The lowest was 0.72. And the median was 1.07.
TSXV:WOLF's PB Ratio is ranked better than 53.58% of 922
companies
in the Drug Manufacturers industry
Industry Median: 1.91
vs TSXV:WOLF: 1.78
During the past 12 months, Grey Wolf Health's average Book Value Per Share Growth Rate was 6.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 4.60% per year.
During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of Grey Wolf Health was 86.00% per year. The lowest was 4.60% per year. And the median was 45.30% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Grey Wolf Health PB Ratio Related Terms
Grey Wolf Health PB Ratio Historical Data
* Premium members only.
The historical data trend for Grey Wolf Health's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Grey Wolf Health's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Grey Wolf Health PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Grey Wolf Health's PB Ratio distribution charts can be found below:
* The bar in red indicates where Grey Wolf Health's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Grey Wolf Health (TSXV:WOLF) has a PB Ratio of 1.78 as of Jul. 18, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Grey Wolf Health and its competitors. This is 66% above median its historical median of 1.07. Over the past decade, Grey Wolf Health's PB Ratio has ranged from 0.72 to 1.99. According to the industry distribution chart, Grey Wolf Health ranks #428 out of 922 companies in the Drug Manufacturers industry, placing it in the top 46.4%.
Is Grey Wolf Health's PB Ratio too high?
Grey Wolf Health's current PB Ratio of 1.78 is 66% above median its 10-year median of 1.07. Over the past 10 years, this metric has ranged from a low of 0.72 to a high of 1.99. The Drug Manufacturers industry median PB Ratio is 1.91. Grey Wolf Health's value of 1.78 is 6.8% below this industry median. Based on the distribution chart, Grey Wolf Health ranks #428 out of 922 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Grey Wolf Health has a GF Score™ of 52/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Grey Wolf Health's PB Ratio compare to ROL and SCI?
According to the Drug Manufacturers industry distribution chart, Grey Wolf Health ranks #428 out of 922 companies for PB Ratio. This puts Grey Wolf Health in the upper half of its industry. The industry median PB Ratio is 1.91. Grey Wolf Health's value of 1.78 is 6.8% below this benchmark. Historically, Grey Wolf Health's own PB Ratio has ranged from 0.72 to 1.99 over the past decade. While the company's 10-year median is 1.07 vs. the industry median of 1.91, Grey Wolf Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.91, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Grey Wolf Health's current PB Ratio of 1.78 is 6.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Grey Wolf Health and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Grey Wolf Health's current PB Ratio is 1.78, which is 66% above median its own 10-year median of 1.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grey Wolf Health stock overvalued right now?
Based on GuruFocus' analysis, Grey Wolf Health (TSXV:WOLF) is currently considered Significantly Overvalued. The stock's GF Value™ is C$1.10, compared to a current price of C$1.60 — trading 45.5% above its estimated fair value. The current PB Ratio is 1.78, which is 66% above median its 10-year median of 1.07 and 6.8% below the Drug Manufacturers industry median of 1.91. Grey Wolf Health's overall GF Score™ is 52/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Grey Wolf Health (TSXV:WOLF), the current PB Ratio is 1.78 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Grey Wolf Health (TSXV:WOLF) Overvalued in 2026?
Based on GuruFocus' analysis, Grey Wolf Health stock appears to be overvalued.
The current stock price of C$1.60 is trading 45.5% above its estimated GF Value™ of C$1.10.
GuruFocus considers Grey Wolf Health to be Significantly Overvalued.
Key valuation signals for TSXV:WOLF:
PB Ratio: 1.78 (66% above median its 10-year median of 1.07)
GF Value™: C$1.10 vs. price of C$1.60 (45.5% above fair value)
Industry Position: 6.8% below the Drug Manufacturers median (#428 of 922)
No single metric tells the full story. See the TSXV:WOLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Grey Wolf Animal Health Corp focuses on sourcing, in-licensing, acquiring, and compounding branded and generic products for sale in both animal and human health markets in Canada. The Company operates through two reportable segments: the Animal Health segment, which involves the sale, marketing, and distribution of pharmaceutical, nutraceutical, and consumable products to veterinary clinics across Canada; and the Pharmacy segment, which generates the majority of revenue and focuses on compounding pharmaceuticals for both human and animal health markets.
52GF Score
Get the complete analysis for TSXV:WOLF
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:WOLF has been successfully added to your 
